These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35445748)
21. The systemic availability of buprenorphine administered by nasal spray. Eriksen J; Jensen NH; Kamp-Jensen M; Bjarnø H; Friis P; Brewster D J Pharm Pharmacol; 1989 Nov; 41(11):803-5. PubMed ID: 2576057 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs. Della Rocca G; Paoletti F; Conti MB; Galarini R; Chiaradia E; Sforna M; Dall'Aglio C; Polisca A; Di Salvo A Front Vet Sci; 2022; 9():1104152. PubMed ID: 36686155 [TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetics and analgesic effects of extended-release buprenorphine administered subcutaneously in healthy dogs. Barletta M; Ostenkamp SM; Taylor AC; Quandt J; Lascelles BDX; Messenger KM J Vet Pharmacol Ther; 2018 Aug; 41(4):502-512. PubMed ID: 29521421 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy. Barbarossa A; Rambaldi J; Giunti M; Zaghini A; Cunto M; Zambelli D; Valgimigli S; Santoro F; Romagnoli N Vet Anaesth Analg; 2017 May; 44(3):435-443. PubMed ID: 28416162 [TBL] [Abstract][Full Text] [Related]
26. Plasma concentrations and behavioral, antinociceptive, and physiologic effects of methadone after intravenous and oral transmucosal administration in cats. Ferreira TH; Rezende ML; Mama KR; Hudachek SF; Aguiar AJ Am J Vet Res; 2011 Jun; 72(6):764-71. PubMed ID: 21627522 [TBL] [Abstract][Full Text] [Related]
27. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers. Middleton LS; Nuzzo PA; Lofwall MR; Moody DE; Walsh SL Addiction; 2011 Aug; 106(8):1460-73. PubMed ID: 21395892 [TBL] [Abstract][Full Text] [Related]
28. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site. Messenger KM; Davis JL; LaFevers DH; Barlow BM; Posner LP Vet Anaesth Analg; 2011 Jul; 38(4):374-84. PubMed ID: 21501371 [TBL] [Abstract][Full Text] [Related]
29. The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine. Lim SCB; Schug S; Krishnarajah J Pain Med; 2019 Jan; 20(1):143-152. PubMed ID: 29309700 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of buprenorphine following intravenous administration in dogs. Krotscheck U; Boothe DM; Little AA Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651 [TBL] [Abstract][Full Text] [Related]
31. Comparative pharmacokinetics of intravenous fentanyl and buprenorphine in healthy greyhound dogs. KuKanich B; Allen P J Vet Pharmacol Ther; 2014 Dec; 37(6):595-7. PubMed ID: 24684621 [TBL] [Abstract][Full Text] [Related]
32. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats. Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers. Bai SA; Xiang Q; Finn A Clin Ther; 2016 Feb; 38(2):358-69. PubMed ID: 26804639 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the efficacy and adverse effects of sustained-release buprenorphine hydrochloride following subcutaneous administration and buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy. Catbagan DL; Quimby JM; Mama KR; Rychel JK; Mich PM Am J Vet Res; 2011 Apr; 72(4):461-6. PubMed ID: 21453146 [TBL] [Abstract][Full Text] [Related]
35. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study. Parikh N; Goskonda V; Chavan A; Dillaha L Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761 [TBL] [Abstract][Full Text] [Related]
36. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers. Agarwal SK; Kriel RL; Brundage RC; Ivaturi VD; Cloyd JC Epilepsy Res; 2013 Aug; 105(3):362-7. PubMed ID: 23561287 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of buprenorphine following intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta). Kelly KR; Pypendop BH; Christe KL J Vet Pharmacol Ther; 2014 Oct; 37(5):480-5. PubMed ID: 24666428 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs. Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs. Garrett ER; Chandran VR Biopharm Drug Dispos; 1990; 11(4):311-50. PubMed ID: 2340348 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of levofloxacin following oral administration of a generic levofloxacin tablet and intravenous administration to dogs. Madsen M; Messenger K; Papich MG Am J Vet Res; 2019 Oct; 80(10):957-962. PubMed ID: 31556716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]